Page last updated: 2024-08-24

rubitecan and Astrocytoma, Grade IV

rubitecan has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Archer, GE; Chewning, TA; Friedman, HS; McLendon, RE; Ochiai, H; Pernell, CT; Sampson, JH	1
Campone, M; Chollet, P; Fety-Deporte, R; Fumoleau, P; Lacombe, D; Lesimple, T; Menten, J; Paoletti, X; Raymond, E; Stupp, R	1

Trials

1 trial(s) available for rubitecan and Astrocytoma, Grade IV

Article	Year
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme. European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:10 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Camptothecin; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed	2002

Article

Year

Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme.

European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:10

Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Camptothecin; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed

2002

Other Studies

1 other study(ies) available for rubitecan and Astrocytoma, Grade IV

Article	Year
Treatment of neoplastic meningitis with intrathecal 9-nitro-camptothecin. Neurologia medico-chirurgica, 2006, Volume: 46, Issue:10 Topics: Animals; Antineoplastic Agents; Camptothecin; Disease Models, Animal; Glioblastoma; Injections, Spinal; Meningitis; Rats; Rats, Nude	2006